METTL3 not only influences normal and symmetric HSPC/HSC differentiation, HSPC self-renewal, and colony formation ability in normal hematopoiesis but also affects leukemia cell differentiation, proliferation, apoptosis, chemoresistance, and a higher risk of specific ALL or lymphoma. This evidence concerns the gene METTL3 and leukemia.